Login / Signup

Oligometastatic Adenocarcinoma of the Esophagus: Current Understanding, Diagnosis, and Therapeutic Strategies.

Michael P RogersAnthony J DeSantisChristopher G DuCoin
Published in: Cancers (2021)
Esophageal adenocarcinoma is an aggressive cancer of increasing incidence and is associated with poor prognosis. The early recognition of synchronous and metachronous oligometastasis in esophageal adenocarcinoma may allow for prompt intervention and potentially improved survival. However, curative approaches to oligometastatic esophageal disease remain unproven and may represent an area of emerging divergence of opinion for surgical and medical oncologists. We sought to identify the current understanding and evidence for management of oligometastatic esophageal adenocarcinoma by performing a thorough review of the available literature.
Keyphrases
  • poor prognosis
  • squamous cell carcinoma
  • locally advanced
  • long non coding rna
  • randomized controlled trial
  • healthcare
  • rectal cancer
  • risk factors
  • papillary thyroid
  • palliative care
  • lymph node metastasis